- Staat
- MI
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 13.03.2023
- Impfdatum
- 07.02.2022
- Beginn
- 10.02.2023
- Tage bis Beginn
- 368,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute myeloid leukaemia
Acute respiratory failure
Adrenal adenoma
Biopsy bone marrow abnormal
Blood aldosterone
Blood catecholamines
Blood culture negative
Blood smear test abnormal
COVID-19
Central venous catheterisation
Chemotherapy
Computerised tomogram abdomen abnormal
Computerised tomogram abnormal
Computerised tomogram neck
Computerised tomogram thorax abnormal
Cortisol free urine normal
Dehydroepiandrosterone test
Diuretic therapy
Symptomtext
Primary Care Physician at Discharge: DO Hematologist/Oncologist: Dr. Admission Date: 2/10/2023 Discharge Date: 03/11/2023 Patient's Discharge Disposition: Home in stable condition. This is a a 46 yo female with a history of ADHD who presented to the ED on 2/10/23 with findings of elevated WBC and concerns for acute leukemia. Peripheral smear on 2/10 was consistent with acute leukemia. On presentation she had anterior cervical lymphadenopathy and concerns for sinusitis and tonsillitis. CT neck 2/10 showed several mildly enlarged level 1 and 2 lymph nodes as well as mildly prominent retropharyngeal lymph nodes findings concerning for possible tonsillitis/sinusitis. The patient was found to be positive for Covid-19 on admisison. She was treated with dex 2/10-2/15 and Remdesivir and remained stable. Bone marrow biopsy done 2/13 (in IR) was positive for AML, normal kayotype, FLT3-TKD mutated and NPM! Mutated. Panorex with no acute findings. ECHO with LVEF 64%. Hepatitis and HIV were negative. HLA typing was sent. PICC line was placed 2/15. She started induction chemo on 2/15/23 with 7+3 and then started Rydapt/Midostaurin D8-21. Day 21 IR bone marrow done 3/7 showed approximately 80% cellular bone marrow, no evidence of leukemia. She did have recurrent sinus pain and neck swelling. CT sinus/neck on 3/5 showed pansinusitis, possible otomastoiditis. ENT did see her and did not have concern for acute mastoididits. Blood cultures were negative. ID was consulted. She was on broad spectrum antibiotics. . During her nadir she also had neutropenic fevers and recurrent acute hypoxemic respiratory failure. CT thorax 3/5 showed diffuse bilateral interstitial ground glass opacities. ECHO 3/5/23 showed an EF of 55%, previously was 64%. Pulmonary was consulted and felt respiratory failure related to fluid overload vs TRALI/TACO with frequent transfusions. She was started on IV lasix BID and had good results and improvement with diuresis. She developed a rash thought to be related to cefepime and ultimately improved once antibiotics were changed. She was treated with with merrem, vancomycin, micafungin, and nystatin through 3/10 when her counts recovered. ID recommended observing off antibiotics. At discharge they recommended ppx acyclovir but with negative bone marrow biopsy from Day 21 antifungal medications. She was also on IV steroids which will be quickly tapered down at discharge. She has been weaned off O2 inpatient. The patient's counts recovered with no evidence of leukemia on D21 Bone marrow biopsy the patient is stable for discharge home today. PICC line was removed. She lives in the area and would like to get labs on Tuesdays/Thursdays in the office but will follow-up with Dr. at clinic. Per weekend attending she will need another IR bone marrow biopsy next week now that her counts have recovered. We will arrange outpatient IR bone marrow biopsy and f/u with Dr. after that is done. She is discharging home in stable condition. Incidental findings this admission: -CT sinuses 3/5 showed prominence of the sella- probably related to empty sella-- patient was asymptomatic with these findings. -CT AP 2/10 showed splenomegaly, multiple vascular lesions throughout liver-likely hemangiomas and MRI abdomen 2/14 showed focal nodular hyperplasia in the right lobe of liver. Has had Mild LFT elevation, but stable. -CT AP 2/14 showed complex partially exophytic cyst at the upper pole of right kidney, ? Bosniak III cyst. Urology plans f/u in 4 months to discuss further treatment plan. -MRI 2/14 right adrenal adenoma- urology evaluated-- 24h urine cortisol (<3.4), plasma fractionated metanephrines (<0.20), DHEA sulfate (low at 12.4) and aldosterone (10.7) level
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 29,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Leukocytosis Acute myeloid leukemia not having achieved remission Neutropenic fever Morbid obesity with body mass index (BMI) of 50.0 to 59.9 in adult Tobacco use Adult ADHD Mucositis due to chemotherapy Alternating constipation and diarrhea Counseling regarding advanced care planning and goals of care Dysphagia with left side facial/neck swelling. Acute respiratory failure with hypoxia hx of COVID-19 Bilateral pulmonary infiltrates on Imaging
- Andere Medikamente
- acyclovir (ZOVIRAX) 200 MG capsule amLODIPine (NORVASC) 2.5 MG tablet benzonatate (TESSALON) 100 MG capsule furosemide (LASIX) 20 MG tablet guaiFENesin (MUCINEX) 600 MG 12 hr tablet lidocaine viscous (XYLOCAINE) 2 % solution loperamide (IMO
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 05.09.2022
- Impfdatum
- 22.06.2022
- Beginn
- 22.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anion gap
Aspartate aminotransferase normal
Basophil count decreased
Basophil percentage
Blood albumin decreased
Blood alkaline phosphatase normal
Blood bilirubin normal
Blood calcium normal
Blood chloride increased
Blood creatinine increased
Blood glucose normal
Blood potassium normal
Blood sodium normal
Blood urea increased
Carbon dioxide normal
Chest X-ray normal
Electrocardiogram abnormal
Eosinophil count decreased
Symptomtext
Narrative: 6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- PHYSICAL EXAM: Current Vitals: T: 98.2 F [36.8 C] (06/22/2022 14:30) P: 70 (06/22/2022 14:30) R: 16 (06/22/2022 14:30) BP: 141/78 (06/22/2022 14:30) Pain: 0 (06/22/2022 14:30) Height: 65 in [165.1 cm] (03/29/2019 09:03) Weight: 137 lb [62.14 kg] (06/22/2022 14:50) BMI: 22.8 (06/22/2022) Pulse Oximetry: 98% room air LABS:TROP-I iSTAT: 0.00 TOTAL BILIRUBIN: 0.6 ASAT: 14 ALKALINE PHOSPHATE: 60 TOTAL PROTEIN: 6.6 ALBUMIN: 3.4 L SODIUM: 144 POTASSIUM: 3.7 CHLORIDE: 107 CO2: 26 ANION GAP (CALCULATED): 11 GLUCOSE: 133 H CREATNINE: 1.5 H CALCIUM 9.7 ALT: <5 EGFR: 49 UREA, BUN: 22 WBC: 5.9 RBC: 3.93 HGB: 10.8 L HCT: 34.3 L MCV: 87.3 MCH: 27.5 MCHC: 31.5 L RDW: 14.4 PLT: 207 MPV: 8.7 EOSINO, ABSOLUTE: 0.0 BASO, ABSOLUTE: 0.0 GRAN %: 83.8 H LYMPH %: 9.2 L MONO %: 6.2 EOS%: 0.3 BASO%: 0.5 GRAN#: 5.0 LYMPH#: 0.5 L MONO: 0.4 MDW: 21.19 H* GLUCOSE POC: 143 Chest x-ray Impression: No significant abnormalities at the chest. EKG: Sinus bradycardia with a rate of 53, normal axis, no ST-T changes, no STEMI
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 12.08.2022
- Impfdatum
- 11.08.2022
- Beginn
- 11.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyskinesia
Fall
Head injury
Pallor
Syncope
Symptomtext
Client fainted within 5-10 minutes of receiving shot. Not witnessed by health department staff. According to witness, Client waiting in line to get back to school pictures taken when she took a couple of steps backwards and then fell back onto the carpeted floor. Jerking movements observed. Client hit back of head witness said and also said she woke right up. Client's legs propped up. Once staff from Health department arrived client assisted up and moved to classroom where it was cooler. Given water and juice to drink. Reassured client, mom, and witness that fainting was fairly normal for this age group after vaccine as well as the jerking movements. Client stated she only had a piece of toast for breakfast and no fluids. Client started to turn pale again. Was laid down and legs elevated. Did not pass out again. After 5-7 minutes of lying down. Sat up and encouraged to finish drinking juice and water. Observed client for another 10 minutes. Discussed with parent to watch for signs of concussion. Client did not complain of any head pain or HA when questioned. Denied nausea. Follow Up phone call 8/12/2022 to mom. Mom stated client did fine the rest of that day and this morning. Denies headache or other signs of concussion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown. Stated not sick today or had any vaccinations within 4 weeks
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 25.05.2022
- Impfdatum
- 25.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Gingival bleeding
Lip haemorrhage
Syncope
Symptomtext
After giving the 3 vaccines, I was by the door leaving the room and I heard the child's mom screaming for help because the patient faint. I turned around and saw patient lying on the floor, he was bleeding from his gums and lips , I hold him while the Dr went into the room with the other nurse. Dr did an examination to the patient vital sign were steady. We put some gauze into child's mouth to stop the bleeding. We gave water to the patient while he was sitting down. We observed him for 1 hour, vital signs were steady and we release him to go home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 07.04.2022
- Impfdatum
- 28.02.2022
- Beginn
- 14.03.2022
- Tage bis Beginn
- 14,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
CSF protein increased
Facial paralysis
Guillain-Barre syndrome
Hypoaesthesia
Lumbar puncture abnormal
Symptomtext
she was diagnosed with Guillain-Barre syndrome post vaccination; she had a facial droop; Patient started having right toe numbness. The right toe then spread to her hands; Initial information received on 01-Apr-2022 regarding an unsolicited valid serious case received via other health professional. This case involves an unknown age female patient who experienced she was diagnosed with guillain-barre syndrome post vaccination, patient started having right toe numbness. the right toe then spread to her hands and she had a facial droop after receiving vaccines MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Menactra) and DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (Adacel). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Feb-2022, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE and a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (dose, route, lot number and administration site: unknown) for Prophylactic vaccination. It was reported that the employee was vaccinated on 28-Feb-2022. All vaccines were work related, Menactra, Fluozne Quiv, and Adacel. On 14-Mar-2022 the employee started having right toe numbness and the right toe then spread to her hands (hypoaesthesia) (latency: 17 days) and on 20-Mar-2022 noticed she had a facial droop (facial paralysis) (latency: 23 days) and she was admitted to the hospital 20-Mar to 26-Mar where she was diagnosed with Guillain-Barre syndrome post vaccination (guillain-barre syndrome) (event onset and latency: unknown). Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events (Patient started having right toe numbness. The right toe then spread to her hands, she had a facial droop, she was diagnosed with Guillain-Barre syndrome post vaccination). At time of reporting, the outcome was Unknown for the events patient started having right toe numbness. the right toe then spread to her hands, she had a facial droop, and she was diagnosed with guillain-barre syndrome post vaccination. Seriousness criteria: Medically significant for the events she was diagnosed with Guillain-Barre syndrome post vaccination and she had a facial droop and hospitalization for the event she was diagnosed with Guillain-Barre syndrome post vaccination.; Sender's Comments: Sanofi Company Comment dated on 07-Apr-2022: This case involves an unknown age female patient who experienced she was diagnosed with guillain-barre syndrome post vaccination, and she had a facial droop after receiving vaccines MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Menactra) and DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (Adacel). The time to onset is compatible with the role of the product for she had a facial droop and not known for the other serious event. Based on the limited information provided regarding this case, causal role of the company suspect product cannot be excluded. Further information regarding concurrent condition during vaccination, previous vaccination, tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed for complete assessment of the case. Based upon the reported information, the individual role of the suspect vaccine cannot be assessed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 04.06.2022
- Impfdatum
- 31.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Angiogram normal
Arthralgia
Asthenopia
Blood chloride normal
Blood creatinine normal
Blood glucose normal
Blood potassium normal
Blood sodium normal
Blood test normal
Blood urea normal
Chest X-ray normal
Chest pain
Complement factor C2
Diplopia
Dizziness
Eyelid ptosis
Head discomfort
Headache
Symptomtext
Went for a physical, Tdap was administered after checkup. 5-10 mins after injection, dizziness, lightheaded, shaky, double vision on left eye, heaviness on left forehead, chest pain, tachycardia. Vitals taken prior to incident was 114/69 P: 84, vitals taken during symptoms 145/95 P: 108. 2 hours after, lightheaded, tingling/numbing on left arm, heaviness on left forehead and eye, droopy eye, chest pain, called advise nurse, went to ER. The following day, headache, malaise, droopy eye. 2 days after, mild headache, right wrist, right Achilles joint pain. 3 days after, intermittent dizziness and headache. 4th day after, left shoulder injected site muscle twitching.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- CT Angiogram, XR chest, blood work test (NA, K, CL, C2, BUN, Glucose, CR) all within normal limits. CT findings to follow up w/ PCP.
- Aktuelle Erkrankungen
- 2 weeks prior, mid upper stomachache
- Vorgeschichte
- none
- Andere Medikamente
- Ferrous Fumarate, Multi vitamins (B12, D3, DHA/EPA, Iodine, K2, Zinc, Magnesium, Selenium)
- Allergien
- synthetic fragrance
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Dyspnoea
Pallor
Symptomtext
HPV vaccine, Tdap, meningococcal vaccine given in that order Patient abruptly became short of breath with pallor 0.3 mg EpiPen administered Symptoms abruptly improved Posttreatment side effects included shivering otherwise tolerated administration well
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 05.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal distension
Blood thyroid stimulating hormone
Chest pain
Delirium
Fatigue
Feeling abnormal
Flatulence
Full blood count
Gastric disorder
Glycosylated haemoglobin
Hepatitis viral test
Hypoglycaemia
Impaired work ability
Insomnia
Metabolic function test
Muscle spasms
Pain
Pyrexia
Symptomtext
46 year old student came in today c/o Had Tdap vaccine at 9 am with our nurses and started getting out of it by 5 pm, fever, fogginess and he thought he was doing Ok but could not do work as he felt bad and lied down and went to bed and it was not long when his muscle spasmed in the GI track inside, deep and at times the breathing muscle felt spasm and his fever went too high but not sure how high (he is thinking maybe 104 as his temp ring pointed to 4 points above normal) and was delirious and was talking in his sleep and had pain and could not sleep and the spasm continued on Saturday and got 4 hours of sleep that night but the spasm became less frequent and then on Saturday night he got fruit juices to get bett 46 year old student came in today c/o Had Tdap vaccine at 9 am with our nurses on 04/01/2022 and started getting out of it by 5 pm, fever, fogginess and he thought he was doing Ok but could not do work as he felt bad and lied down and went to bed and it was not long when his muscle spasmed in the GI track inside, deep and at times the breathing muscle felt spasm and his fever went too high but not sure how high (he is thinking maybe 104 as his temp ring pointed to 4 points above normal) and was delirious and was talking in his sleep and had pain and could not sleep and the spasm continued on Saturday and got 4 hours of sleep that night but the spasm became less frequent and then on Saturday night he got fruit juices to get better hydrated and some of the fruits he does not usually eat, banana and mango and it made more gas and re trigger the spasm. Then got better yesterday evening. Got 4 hours of sleep last night. Today he feels tired, he did not feel spasm but it felt his stomach muscle were not working to move and felt increase gas from the fruit and felt distended and more painful and felt expanding up to his chest and had DIB if he lies down, better with sitting up and did exercise and stretching which helped and no more chest pain. had BM this am, small pieces, not hard at his normal, no blood. He is passing gas today but not yesterday. Drank 2 L of fluid a day. His diet "Weird" "concentrated powder food that he devolve and take it as meal replacement and only eats 2 meals a week consistent with shredded wheat and apple" which is not new for the past 7 years. He started that initially started doing that for efficiency and helped with hypoglycemia, drinks enough fluid. Goes once a day BM, does not strain and takes fiber supplements. Gets dirt and cuts all the time and he feels he got natural immunization to dirt. He had horrible sleep the entire week even before the vaccine. That is not usual for him where he gets bad sleep for a week or so. When he does not sleep well his body does does not regulate his temp. Took aleve and it helped.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 04/04/2022 CBC, CMP, Hepatitis panel Vit B12, Vit D-25-OH,Hemoglobin A1C, UA, TSH, and Abd KUB.
- Aktuelle Erkrankungen
- ADD,Other disturbances of skin sensation
- Vorgeschichte
- ADD, unknown GI issue.
- Andere Medikamente
- Adderall 10 mg, Vyvanse 60 mg, gabapentin 100 mg, "Weird" "con
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 22.06.2023
- Impfdatum
- 24.05.2022
- Beginn
- 24.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Chills
Erythema
Hypersensitivity
Injection site rash
Myalgia
Swelling
Symptomtext
allergic reaction to the Tdap; rash approximately 5 inches at and around the injection site; chills; muscle soreness; joint soreness and aches; swelling; erythema; Initial information received on 27-May-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 11 years old male patient who had allergic reaction to the tdap, chills, muscle soreness, joint soreness and aches, swelling, erythema and rash approximately 5 inches at and around the injection site while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 24-May-2022, the patient received a fifth dose of 0.5 ml of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE , (lot: U7271AA ; expiry date: not reported) via intramuscular route in the left deltoid for immunization. On the same day, the patient developed a non-serious event of allergic reaction to the tdap (allergy to vaccine) , chills , muscle soreness (myalgia), joint soreness and aches (arthralgia), swelling, erythema, rash approximately 5 inches at and around the injection site (vaccination site rash) following the fifth dose administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. The patient's mother took him to urgent care on 25-May-2022 and they gave medications to soothe the symptoms Action taken : not applicable for all the events. The patient was treated with PARACETAMOL (TYLENOL), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) , LORATADINE (CLARITIN [LORATADINE]) and IBUPROFEN (IBUPROFEN) for Vaccination site rash, Allergy to vaccine, Chills, Myalgia, Arthralgia, Swelling and Erythema. Outcome: not recovered for all the events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 02.03.2023
- Impfdatum
- 27.02.2023
- Beginn
- 27.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain in extremity
Peripheral swelling
Symptomtext
right arm swelling, erythema and pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 07.11.2022
- Impfdatum
- 03.05.2022
- Beginn
- 07.11.2022
- Tage bis Beginn
- 188,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Symptomtext
Patient reports to having left shoulder pain starting that same evening of 5/8/2022, and reports that he is still having this today 11/7/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- HTN and long standing Chronic Left Shoulder Pain
- Andere Medikamente
- Albuterol Sulfate 108 (90 Base) MCG/ACT 2 Puffs Inhalation Every 6 hours PRN, Need appt before next refill. Aspirin 81 MG Take by mouth. Cyanocobalamin,Methylcobalamin Take by mouth. Fish Oil by Does not apply route. Fluticasone-Salme
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 16.07.2022
- Impfdatum
- 14.06.2022
- Beginn
- 14.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Pyrexia
Symptomtext
104 degree fever experienced by patient that evening after injection left arm still sore as of 7/16/22, over 1 month later Referred to md by us.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- none; Patient waiting until August appointment to see md. They thought it was related to the injection.
- Aktuelle Erkrankungen
- hypertension COPD ulcers hyperchloesteremia
- Vorgeschichte
- COPD
- Andere Medikamente
- Per patient report (other store) simvastatin 40 mg qd lisinopril 10mg qd vit d 2,000 units qd trilegy 1 puff qd albuterol neb soln 1 vial prn albuterol inhaler 2 puffs prn At our store: Esomeprazole 40 mg bid
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 24.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Malaise
Respiratory symptom
Symptomtext
Mom reported a few days of upper respiratory symptoms, and per mom states he was pretty sick. He also received his Tdap at the same time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- no
- Andere Medikamente
- multivitamin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 19.04.2022
- Impfdatum
- 12.04.2022
- Beginn
- 12.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain
Pruritus
Swelling
Urticaria
Symptomtext
Patient reported to the pharmacy and said she's experiencing a reaction from her tetanus shot from 4/12. She developed some localized pain/swelling shortly after receiving the injection. She rubbed her arm continuously in hopes of relieving the reaction. She started to experience itching on Saturday. Present day, the area has about a 2 1/2 inch, raised whelp that was slightly red. No other symptoms since the injection. I advised the patient to take oral benadryl and to see her dr if it does not resolve.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 28.03.2022
- Impfdatum
- 25.03.2022
- Beginn
- 26.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Pyrexia
Swelling
Symptomtext
Swelling, soreness 16 hours later, low grade fever 24 hours later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- endometriosis
- Andere Medikamente
- birth control
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 25.02.2022
- Impfdatum
- 23.02.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Arthritis
Axillary pain
Symptomtext
Pain in the Arm pit and Sholder
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Denied
- Vorgeschichte
- Denied
- Andere Medikamente
- Tylenol
- Allergien
- Denied
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 18.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Eye swelling
Photophobia
Symptomtext
diarrhea x 30 hrs, swelling of both eyes and extreme light sensitivity within 8 hrs of receiving injection. light sensitivity lasted for days. 3 days later, patient said it was slowly dissipating.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- multiple - DM, HTN, anemia, kidney transplant 2018, BKA left, CAD and many others
- Andere Medikamente
- Daily medications: ASA 325mg, Vit D3 125mcg, Co Q-10 30mg, Vytorin 10-10mg, Toprol LX 100mg 24hr tab, Vit B complex. Other meds: Lantus Solostar U-100 Insulin per sliding scale, Humalog Kwik Pen 15U at dinner, Myfortic 180mg EC tab - 2 tabs
- Allergien
- High/critical allergies: Vancomycin and Valsartan Low allergy: Penicillins Not specified: amlodipine, cephalexin, codeine, difluprednate, lisinopril, spice flavor, Tylenol with codeine#2
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 05.12.2022
- Impfdatum
- 05.12.2022
- Beginn
- 05.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administration error
Wrong product administered
Symptomtext
12/5/2022 ADMINSTION ERROR - Men quad was order and bexero was given. And pt. left the office but we need to bring her back to give correct vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NONE - no ill effects
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- eczema
- Andere Medikamente
- NO
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 08.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Adacel was given to a 4 year old with no reported adverse event; Initial information received on 02-Aug-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 4 years old male patient to whom DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] was given to a 4 year old with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) for Prophylactic vaccination. On 02-Aug-2022, the patient received a fifth dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE, with an unknown formulation and strength, at dose of 0.5 ml (frequency: once) ( lot: U7271AA ; expiry date: 12-Jan-2024) via intramuscular route in the right thigh for immunization. It was reported that Adacel was given to a 4 year old with no reported adverse event (product administered to patient of inappropriate age) (latency: same day) Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 02.05.2022
- Impfdatum
- 25.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Erythema
Induration
Skin warm
Swelling
Symptomtext
pt received both vaccines in same arm(left) on 04/25/2022 by MA on 04/25/2022 per NP pt called to be checked on Friday after swelling redness hard and hot to touch unable to know which one of vaccines gave this reaction.pt put on antibiotics for cellulitis will check back if not resolved
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma
- Andere Medikamente
- diazepam junel singulair xyzal
- Allergien
- bacitracin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.04.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
vaccine was exposed to 70 F got 117 hours and 5 minutes. with no adverse event; Initial information received on 18-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient who experienced vaccine was exposed to 70 f got 117 hours and 5 minutes. with no adverse event while receiving vaccine Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect diphtheria 2/tetanus/5 ac pertussis vaccine (lot number: U7271AA) (unknown strength, dose, route, dosage form and expiration date) via unknown route in unknown administration site. On an unknown date the patient developed a non-serious event vaccine was exposed to 70 F got 117 hours and 5 minutes. with no adverse event (Product storage error) (unknown latency) following the administration of diphtheria 2/tetanus/5 ac pertussis vaccine. Action taken: Not applicable. Corrective treatment: Not provided. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 04.04.2022
- Impfdatum
- 17.03.2022
- Beginn
- 17.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
Extra dose administered
No adverse event
Symptomtext
received an extra dose of ADACEL, with no reported adverse event; patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine , with no reported adverse event; Initial information received on 29-Mar-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 28 years old female patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine , with no reported adverse event and received an extra dose of ADACEL, with no reported adverse event, while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL]. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported patient who is pregnant received an extra dose of ADACEL, with no reported adverse event occurred at 28 weeks of pregnancy and received an extra dose of ADACEL, with no reported adverse event occurred at 29 weeks of pregnancy and the patient was exposed to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE at 28 weeks of pregnancy, during third pregnancy trimester for DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. The date of last menstrual period was reported as 05-Sep-2021. The estimated due date is 12-Jun-2022. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Mar-2022, the patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine (exposure during pregnancy) (latency: same day) (lot U7271AA : expiry date: 22-NOV-2024) via intramuscular route in the left deltoid for immunization. On 28-Mar-2022 she also received a extra dose of the same vaccine (extra dose administered) (latency: 11 days) via intramuscular route in the left deltoid . On 28-MAR-2022 the patient developed a non-serious patient who is 29 weeks and 2 days pregnant received an extra dose of adacel, with no reported adverse event (exposure during pregnancy) and non-serious patient who is 29 weeks and 2 days pregnant received an extra dose of adacel, with no reported adverse event (extra dose administered) 11 days following the administration of diphtheria-2/tetanus/5 AC pertussis vaccine. It was reported " patient who is 29 weeks and 2 days pregnant received an extra dose of ADACEL. Caller reporting patient received first dose on 17-Mar-2022 and inadvertently received a second dose on 28-Mar-2022." Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) was not applicable. It was not reported if the patient received a corrective treatment for the events (patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine , with no reported adverse event, received an extra dose of ADACEL, with no reported adverse event). At time of reporting, the outcome was Unknown for the event patient who is pregnant received a dose of 0.5 ml of suspect diphtheria-2/tetanus/5 ac pertussis vaccine , with no reported adverse event and was Unknown for the event received an extra dose of adacel, with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 04.04.2022
- Impfdatum
- 17.03.2022
- Beginn
- 17.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
Extra dose administered
No adverse event
Symptomtext
received an extra dose of ADACEL, with no reported adverse event; patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine , with no reported adverse event; Initial information received on 29-Mar-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 28 years old female patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine , with no reported adverse event and received an extra dose of ADACEL, with no reported adverse event, while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL]. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported patient who is pregnant received an extra dose of ADACEL, with no reported adverse event occurred at 28 weeks of pregnancy and received an extra dose of ADACEL, with no reported adverse event occurred at 29 weeks of pregnancy and the patient was exposed to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE at 28 weeks of pregnancy, during third pregnancy trimester for DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. The date of last menstrual period was reported as 05-Sep-2021. The estimated due date is 12-Jun-2022. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Mar-2022, the patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine (exposure during pregnancy) (latency: same day) (lot U7271AA : expiry date: 22-NOV-2024) via intramuscular route in the left deltoid for immunization. On 28-Mar-2022 she also received a extra dose of the same vaccine (extra dose administered) (latency: 11 days) via intramuscular route in the left deltoid . On 28-MAR-2022 the patient developed a non-serious patient who is 29 weeks and 2 days pregnant received an extra dose of adacel, with no reported adverse event (exposure during pregnancy) and non-serious patient who is 29 weeks and 2 days pregnant received an extra dose of adacel, with no reported adverse event (extra dose administered) 11 days following the administration of diphtheria-2/tetanus/5 AC pertussis vaccine. It was reported " patient who is 29 weeks and 2 days pregnant received an extra dose of ADACEL. Caller reporting patient received first dose on 17-Mar-2022 and inadvertently received a second dose on 28-Mar-2022." Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) was not applicable. It was not reported if the patient received a corrective treatment for the events (patient who is pregnant received a dose of 0.5 ml of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine , with no reported adverse event, received an extra dose of ADACEL, with no reported adverse event). At time of reporting, the outcome was Unknown for the event patient who is pregnant received a dose of 0.5 ml of suspect diphtheria-2/tetanus/5 ac pertussis vaccine , with no reported adverse event and was Unknown for the event received an extra dose of adacel, with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
patient was 18 weeks and 6 days pregnant at the time of administration- with no reported adverse event; Initial information received on 21-Feb-2022 regarding an unsolicited valid non-serious case via Other Healthcare professional. This case involves a 25 years old female patient who was exposed to Diphtheria-2/Tetanus/5 AC Pertusis Vaccine [Adacel] in context of patient was 18 weeks and 6 days pregnant at the time of administration- with no reported adverse event. The date of last menstrual period was reported as 27-Sep-2021. The estimated due date is 12-Jul-2022. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported patient was exposed to Diphtheria-2/Tetanus/5 AC Pertusis Vaccine at 21 weeks of pregnancy, during second pregnancy trimester. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 14-Feb-2022, the patient received 0.5 ml dose of Diphtheria-2/Tetanus/5 AC Pertusis Vaccine suspension for injection (lot number: U7271AA and expiry date: 12-Jan-2024) once via intramuscular route in an unknown administration site for immunization. On 14-Feb-2022, patient was 18 weeks and 6 days pregnant at the time of administration- with no reported adverse event (exposure during pregnancy) (latency: same day) following the administration of Diphtheria-2/Tetanus/5 AC Pertusis Vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event exposure during pregnancy. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
The patient was given a second dose of TDAP in error. He received a dose on 2/19/2018
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -